Improving Therapeutic Vaccination against Hepatitis B—Insights from Preclinical Models of Immune Therapy against Persistent Hepatitis B Virus Infection
Chronic hepatitis B affects more than 250 million individuals worldwide, putting them at risk of developing liver cirrhosis and liver cancer. While antiviral immune responses are key to eliminating hepatitis B virus (HBV) infections, insufficient antiviral immunity characterized by failure to elimin...
Guardado en:
Autores principales: | Percy A. Knolle, Li-Rung Huang, Anna Kosinska, Dirk Wohlleber, Ulrike Protzer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/312508e884104ee695c394701ea6736e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Assessment of anti-HBs antibody concentration in children with juvenile idiopathic arthritis treated with biological drugs, vaccinated against viral type B hepatitis in infancy
por: Izabela Szczygielska, et al.
Publicado: (2020) -
Surveying children and adult vaccination program against diphtheria, tetanus, measles and viral hepatitis B in the Russian Federation
por: N. P. Galina, et al.
Publicado: (2020) -
Inmunogenicidad de una vacuna recombinante anti hepatitis B en personal de salud
por: GARCÍA C.,PATRICIA, et al.
Publicado: (2002) -
Importancia de las vacunas contra los virus de las hepatitis A y B en Chile
por: Valenzuela B,M Teresa
Publicado: (2009) -
Distinct Cytokine Profiles Correlate with Disease Severity and Outcome in Longitudinal Studies of Acute Hepatitis B Virus and Hepatitis D Virus Infection in Chimpanzees
por: Ronald E. Engle, et al.
Publicado: (2020)